reference/35499061

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35499061

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	10781
issn	0022-2623 1520-4804
issueIdentifier	15
pageRange	10761-10781
publicationName	Journal of Medicinal Chemistry
startingPage	10761
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_aa048e23fd0358a0129a26ab8c57f3bb http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6649748e4ee91622678c147ddd121468 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fca73b6cef5d3df56e19b2d238cde805
bibliographicCitation	Yang L, Tu W, Huang L, Miao B, Kaneshige A, Jiang W, Leng L, Wang M, Wen B, Sun D, Wang S. Discovery of SMD-3040 as a Potent and Selective SMARCA2 PROTAC Degrader with Strong in vivo Antitumor Activity. J Med Chem. 2023 Aug 10;66(15):10761–81. doi: 10.1021/acs.jmedchem.3c00953. PMID: 37523716.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_62dfe5931d8784939237ea34eb7b3c35 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_00a79b4c868f79caf6fbe67ca97d5f2b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_741734cd7dc29bb1028a5f74caeee1c9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6406-2126 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f749cfdca0d90dd1b6d4e4932dc98ecc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_79179df1483e3512c4b2caf6e3b60eaf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_745525dc5da5d3fd0149884c643f275f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a0220ccc753a1b8e0d59d05137ec9956 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8782-6950 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_57829fab3c081f64242996c7c1136449 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c595f95634a1bc833bf527debac36c8
date	2023-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1021/acs.jmedchem.3c00953 https://pubmed.ncbi.nlm.nih.gov/37523716
isPartOf	https://portal.issn.org/resource/ISSN/1520-4804 https://portal.issn.org/resource/ISSN/0022-2623 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4938
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Discovery of SMD-3040 as a Potent and Selective SMARCA2 PROTAC Degrader with Strong in vivo Antitumor Activity
discusses	http://id.nlm.nih.gov/mesh/M0021788 http://id.nlm.nih.gov/mesh/M0223362 http://id.nlm.nih.gov/mesh/M0223589 http://id.nlm.nih.gov/mesh/M0006674 http://id.nlm.nih.gov/mesh/M0015042
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014157 http://id.nlm.nih.gov/mesh/D000072020
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D009687 http://id.nlm.nih.gov/mesh/D004265 http://id.nlm.nih.gov/mesh/D059748
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6084099a23b212b43337b538c99a086d http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a0ac940a62f0d7eb32fac70cdc945dea

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6597 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6595 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID483123390

Total number of triples: 52.